Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Malaria Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Malaria Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Malaria Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Malaria Drugs Market Size Growth Rate by Type
    • 1.4.2 Aryl Aminoalcohol Compounds
    • 1.4.3 Antifolate Compounds
    • 1.4.4 Artemisinin Compounds
  • 1.5 Market by Application
    • 1.5.1 Global Malaria Drugs Market Size Growth Rate by Application
    • 1.5.2 Prevention
    • 1.5.3 Treatment
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Malaria Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Malaria Drugs Revenue 2015-2026
    • 2.1.2 Global Malaria Drugs Sales 2015-2026
  • 2.2 Global Malaria Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Malaria Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Malaria Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Malaria Drugs Competitor Landscape by Players

  • 3.1 Malaria Drugs Sales by Manufacturers
    • 3.1.1 Malaria Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Malaria Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Malaria Drugs Revenue by Manufacturers
    • 3.2.1 Malaria Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Malaria Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Malaria Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Malaria Drugs Revenue in 2019
    • 3.2.5 Global Malaria Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Malaria Drugs Price by Manufacturers
  • 3.4 Malaria Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Malaria Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Malaria Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Malaria Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Malaria Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Malaria Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Malaria Drugs Revenue by Type (2015-2020)
    • 4.1.3 Malaria Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Malaria Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Malaria Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Malaria Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Malaria Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Malaria Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Malaria Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Malaria Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Malaria Drugs Revenue by Application (2015-2020)
    • 5.1.3 Malaria Drugs Price by Application (2015-2020)
  • 5.2 Malaria Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Malaria Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Malaria Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Malaria Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Malaria Drugs by Country
    • 6.1.1 North America Malaria Drugs Sales by Country
    • 6.1.2 North America Malaria Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Malaria Drugs Market Facts & Figures by Type
  • 6.3 North America Malaria Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Malaria Drugs by Country
    • 7.1.1 Europe Malaria Drugs Sales by Country
    • 7.1.2 Europe Malaria Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Malaria Drugs Market Facts & Figures by Type
  • 7.3 Europe Malaria Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Malaria Drugs by Region
    • 8.1.1 Asia Pacific Malaria Drugs Sales by Region
    • 8.1.2 Asia Pacific Malaria Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Malaria Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Malaria Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Malaria Drugs by Country
    • 9.1.1 Latin America Malaria Drugs Sales by Country
    • 9.1.2 Latin America Malaria Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Malaria Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Malaria Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Malaria Drugs by Country
    • 10.1.1 Middle East and Africa Malaria Drugs Sales by Country
    • 10.1.2 Middle East and Africa Malaria Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Malaria Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Malaria Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Cipla
    • 11.1.1 Cipla Corporation Information
    • 11.1.2 Cipla Description and Business Overview
    • 11.1.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Cipla Malaria Drugs Products Offered
    • 11.1.5 Cipla Related Developments
  • 11.2 Guilin Pharmaceutical
    • 11.2.1 Guilin Pharmaceutical Corporation Information
    • 11.2.2 Guilin Pharmaceutical Description and Business Overview
    • 11.2.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Guilin Pharmaceutical Malaria Drugs Products Offered
    • 11.2.5 Guilin Pharmaceutical Related Developments
  • 11.3 IPCA Laboratories
    • 11.3.1 IPCA Laboratories Corporation Information
    • 11.3.2 IPCA Laboratories Description and Business Overview
    • 11.3.3 IPCA Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 IPCA Laboratories Malaria Drugs Products Offered
    • 11.3.5 IPCA Laboratories Related Developments
  • 11.4 GlaxoSmithKline
    • 11.4.1 GlaxoSmithKline Corporation Information
    • 11.4.2 GlaxoSmithKline Description and Business Overview
    • 11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 GlaxoSmithKline Malaria Drugs Products Offered
    • 11.4.5 GlaxoSmithKline Related Developments
  • 11.5 Mylan Labs
    • 11.5.1 Mylan Labs Corporation Information
    • 11.5.2 Mylan Labs Description and Business Overview
    • 11.5.3 Mylan Labs Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan Labs Malaria Drugs Products Offered
    • 11.5.5 Mylan Labs Related Developments
  • 11.6 Roche
    • 11.6.1 Roche Corporation Information
    • 11.6.2 Roche Description and Business Overview
    • 11.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Roche Malaria Drugs Products Offered
    • 11.6.5 Roche Related Developments
  • 11.7 Novartis
    • 11.7.1 Novartis Corporation Information
    • 11.7.2 Novartis Description and Business Overview
    • 11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Novartis Malaria Drugs Products Offered
    • 11.7.5 Novartis Related Developments
  • 11.8 Sanofi Aventis
    • 11.8.1 Sanofi Aventis Corporation Information
    • 11.8.2 Sanofi Aventis Description and Business Overview
    • 11.8.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Sanofi Aventis Malaria Drugs Products Offered
    • 11.8.5 Sanofi Aventis Related Developments
  • 11.9 Ajanta Pharma
    • 11.9.1 Ajanta Pharma Corporation Information
    • 11.9.2 Ajanta Pharma Description and Business Overview
    • 11.9.3 Ajanta Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Ajanta Pharma Malaria Drugs Products Offered
    • 11.9.5 Ajanta Pharma Related Developments
  • 11.10 Kunming Pharmaceutical
    • 11.10.1 Kunming Pharmaceutical Corporation Information
    • 11.10.2 Kunming Pharmaceutical Description and Business Overview
    • 11.10.3 Kunming Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Kunming Pharmaceutical Malaria Drugs Products Offered
    • 11.10.5 Kunming Pharmaceutical Related Developments
  • 11.1 Cipla
    • 11.1.1 Cipla Corporation Information
    • 11.1.2 Cipla Description and Business Overview
    • 11.1.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Cipla Malaria Drugs Products Offered
    • 11.1.5 Cipla Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Malaria Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Malaria Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Malaria Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Malaria Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Malaria Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Malaria Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Malaria Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Malaria Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Malaria Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Malaria Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Malaria Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Malaria Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Malaria Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Malaria Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Malaria Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Malaria Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Malaria Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Malaria Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Malaria Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Malaria Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Malaria Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Malaria Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Malaria Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Malaria Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Malaria Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Malaria Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Malaria Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Malaria Drugs market is segmented into
    Aryl Aminoalcohol Compounds
    Antifolate Compounds
    Artemisinin Compounds

    Segment by Application, the Malaria Drugs market is segmented into
    Prevention
    Treatment
    Other

    Regional and Country-level Analysis
    The Malaria Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Malaria Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Malaria Drugs Market Share Analysis
    Malaria Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Malaria Drugs business, the date to enter into the Malaria Drugs market, Malaria Drugs product introduction, recent developments, etc.

    The major vendors covered:
    Cipla
    Guilin Pharmaceutical
    IPCA Laboratories
    GlaxoSmithKline
    Mylan Labs
    Roche
    Novartis
    Sanofi Aventis
    Ajanta Pharma
    Kunming Pharmaceutical

    Buy now